Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-TL1A/TNFSF15 Antibody (7F38) is an antibody targeting TL1A/TNFSF15. Anti-TL1A/TNFSF15 Antibody (7F38) can be used in ELISA.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 μL | $209 | 7-10 days | |
| 100 μL | $349 | 7-10 days |
| Description | Anti-TL1A/TNFSF15 Antibody (7F38) is an antibody targeting TL1A/TNFSF15. Anti-TL1A/TNFSF15 Antibody (7F38) can be used in ELISA. |
| Synonyms | VEGI-251, VEGI192A, VEGI, TNFSF15, TL1A, TL1 |
| Ig Type | hIgG1 |
| Clone | 7F38 |
| Reactivity | Human, Cynomolgus, Mouse |
| Verified Activity | 1. The Binding Activity of Biotinylated Macaca mulatta TNFSF15 with Anti-TNFSF15 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Anti-TNFSF15 recombinant antibody at 2 μg/mL can bind Biotinylated Macaca mulatta TNFSF15. The EC50 is 0.2589-0.3025 ng/mL. 2. The Binding Activity of Biotinylated TNFSF15 with Anti-TNFSF15 Recombinant Antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Biotinylated Human TNFSF15 at 2 μg/mL on streptavidin coated plates can bind Anti-TNFSF15 recombinant antibody (TMAH-01193). The EC50 is 0.2732 - 0.6370 ng/mL. 3. The Binding Activity of Mouse Tnfsf15 with Anti-TNFSF15 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Mouse Tnfsf15 at 2 μg/mL can bind Anti-TNFSF15 recombinant antibody. The EC50 is 1.671-2.506 ng/mL. |
| Application | |
| Recommended Dose | ELISA:1:5000-1:50000. |
| Antibody Type | Monoclonal |
| Subcellular Localization | Membrane; Single-pass type II membrane protein.; [Tumor necrosis factor ligand superfamily member 15, secreted form]: Secreted. |
| Tissue Specificity | Specifically expressed in endothelial cells. Detected in monocytes, placenta, lung, liver, kidney, skeletal muscle, pancreas, spleen, prostate, small intestine and colon. |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| Research Background | Receptor for TNFRSF25 and TNFRSF6B. Mediates activation of NF-kappa-B. Inhibits vascular endothelial growth and angiogenesis (in vitro). Promotes activation of caspases and apoptosis. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human TNFSF15 Protein |
| Antigen Species | Human |
| Gene Name | TNFSF15 |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Immunology |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.